Clinical Trial Detail

NCT ID NCT02046122
Title Adoptive Transfer of Haplo-identical DLI for AML and MDS
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Duke University
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin

Age Groups: senior adult

No variant requirements are available.